Herbalife (HLF) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $0.51
- Estimate
- $0.54
- Surprise
- -4.9%
- Revenue (period 2026-06-30)
- $1.33B
- Score at report (before → after)
- 6.1 → 6.3/10
Revenue source: xbrl.
How the report landed
Herbalife (HLF) missed the $0.54 estimate with adjusted EPS of $0.51 — a clear 4.9% shortfall. TrendMatrix's engine moved from Buy (Wait) (6.1/10) to Hold at 6.3/10 after the report — the engine's score rose despite the miss.
Where TrendMatrix's rating stands now
TrendMatrix currently rates HLF Sell at 6.1/10.
2 of the last 4 quarters beat the estimate; this quarter's -4.9% surprise compares with a -0.3% four-quarter average. Next scheduled report: 2026-11-02.
What supports the rating
- Sector modifier (Consumer Defensive): +0.8
- Attractive valuation
What argues against it
- Concentration risk — Product: Weight Management (54.5%)
- Concentration risk — Customer: independent Members
- Analyst target reached - limited upside remaining
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $14.59
- Stop
- $13.57
The stock trades at 8.5× trailing but 4.3× forward earnings — consensus estimates already build in a substantial earnings recovery.
Model outputs from TrendMatrix’s engine as of 2026-11-03 — shown for context, not personalized investment advice.
HLF at TrendMatrix's latest read
Defensive staples are judged on margin resilience: pricing power against input costs matters more here than top-line drama.
- Industry
- Packaged Foods
- Market cap
- $1.39B
- P/E (fwd)
- 4.3
- P/E (ttm)
- 8.5
- 52-week range
- $7.69–$20.40
- Off 52-week high
- 28.5%
- RSI (14)
- 55
- Volume vs avg
- 0.41×
- Score today
- 6.1/10